Physician profile
Leonardo E Salcedo
NPI 1407975048
$7,888.54
in general payments reported to CMS, 2019-2025
21 companies · $2,426 in 2025
The $2,426 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,817 · 2020: $296 · 2021: $857 · 2022: $776 · 2023: $712 · 2024: $1,004 · 2025: $2,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,323 · Travel and Lodging: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,323.09 |
| Travel and Lodging | $818.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,329.28 | 2019-2024 | Merlin@Home, Assurity, Cardiomems |
| Cvrx, INC. | $1,421.34 | 2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $851.83 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $506.21 | 2019-2025 | Farxiga, Lokelma |
| Medtronic, INC. | $433.03 | 2022-2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan |
| Pfizer INC. | $330.61 | 2019-2025 | |
| Abiomed | $288.05 | 2019-2025 | Impella |
| Heartflow, INC. | $273.65 | 2022-2024 | |
| Amgen INC. | $271.32 | 2020-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $255.76 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $210.06 | 2022-2025 | |
| Novo Nordisk INC | $163.75 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Shockwave Medical, INC | $159.97 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.90 | 2021-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $78.92 | 2023-2025 | Lifevest |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $54.09 | 2023-2025 | Bodyguardian |
| Impulse Dynamics (USA) INC. | $45.52 | 2023 | Optimizer |
| Acist Medical Systems, INC. | $27.07 | 2023 | |
| Siemens Medical Solutions USA, INC. | $22.16 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.16 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $12.86 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonardo Salcedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.